The present invention relates to prognostic methods which are useful in medicine, particularly cancer chemotherapy. The object of the invention to provide a method for assessing Dihydropyrimidine dehydrogenase (DPD) expression levels in tissues and prognosticate the probable resistance of a patient's tumor to treatment with 5-FU based therapies by examination of the amount of DPD mRNA in a patient's tumor cells and comparing it to a predetermined threshold expression level. More specifically, the invention provides to oligonucleotide primer pairs DPD3A and DPD3B and methods comprising their use for detecting levels of Dihydropyrimidine dehydrogenase (DPD) mRNA.

 
Web www.patentalert.com

< Methods for making character strings, polynucleotides and polypeptides having desired characteristics

< Genes involved in the molecular paths of tumor suppression and/or resistance to viruses

> Rapidly degrading GFP-fusion proteins and methods of use

> Bioluminescent assays and bacterial strains useful therein

~ 00215